Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker YFOR
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Yinan Ren | 3.94M | 50.2% | SCHEDULE 13D/A ↗ |
| Aug 18, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Yinan Ren | 3.79M | 48.3% | SCHEDULE 13D/A ↗ |
| Aug 12, 2026 | SCHEDULE 13D | YFOR YYForce Inc. | Yinan Ren | 3.79M | 29.5% | SCHEDULE 13D ↗ |
| Aug 6, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Milton C. Ault III | 151,659 | 4.7% | SCHEDULE 13D/A ↗ |
| Aug 6, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Capital Group, Inc. | 151,658 | 4.7% | SCHEDULE 13D/A ↗ |
| Aug 6, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Lending, LLC | 151,658 | 4.7% | SCHEDULE 13D/A ↗ |
| Aug 6, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | ACG Alpha Management LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 6, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance GP LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 6, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance LP | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 6, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Hyperscale Data, Inc. | 151,658 | 4.7% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Milton C. Ault III | 217,400 | 6.8% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Capital Group, Inc. | 217,399 | 6.8% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Lending, LLC | 217,399 | 6.8% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | ACG Alpha Management LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance GP LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance LP | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Jul 27, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Hyperscale Data, Inc. | 217,399 | 6.8% | SCHEDULE 13D/A ↗ |
| Jul 7, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Milton C. Ault III | 319,917 | 10.0% | SCHEDULE 13D/A ↗ |
| Jul 7, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Capital Group, Inc. | 317,583 | 9.9% | SCHEDULE 13D/A ↗ |
| Jul 7, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Lending, LLC | 232,600 | 7.3% | SCHEDULE 13D/A ↗ |
| Jul 7, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | ACG Alpha Management LLC | 84,983 | 2.7% | SCHEDULE 13D/A ↗ |
| Jul 7, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance GP LLC | 84,983 | 2.7% | SCHEDULE 13D/A ↗ |
| Jul 7, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance LP | 84,983 | 2.7% | SCHEDULE 13D/A ↗ |
| Jul 7, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Hyperscale Data, Inc. | 317,583 | 9.9% | SCHEDULE 13D/A ↗ |
| Jun 22, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Milton C. Ault III | 7.35M | 7.7% | SCHEDULE 13D/A ↗ |
| Jun 22, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Capital Group, Inc. | 7.28M | 7.6% | SCHEDULE 13D/A ↗ |
| Jun 22, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Lending, LLC | 5.03M | 5.2% | SCHEDULE 13D/A ↗ |
| Jun 22, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | ACG Alpha Management LLC | 2.25M | 2.3% | SCHEDULE 13D/A ↗ |
| Jun 22, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance GP LLC | 2.25M | 2.3% | SCHEDULE 13D/A ↗ |
| Jun 22, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance LP | 2.25M | 2.3% | SCHEDULE 13D/A ↗ |
| Jun 22, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Hyperscale Data, Inc. | 7.28M | 7.6% | SCHEDULE 13D/A ↗ |
| Jun 16, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Milton C. Ault III | 5.28M | 5.5% | SCHEDULE 13D/A ↗ |
| Jun 16, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Capital Group, Inc. | 5.23M | 5.4% | SCHEDULE 13D/A ↗ |
| Jun 16, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Lending, LLC | 4.03M | 4.2% | SCHEDULE 13D/A ↗ |
| Jun 16, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | ACG Alpha Management LLC | 1.20M | 1.2% | SCHEDULE 13D/A ↗ |
| Jun 16, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance GP LLC | 1.20M | 1.2% | SCHEDULE 13D/A ↗ |
| Jun 16, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance LP | 1.20M | 1.2% | SCHEDULE 13D/A ↗ |
| Jun 16, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Hyperscale Data, Inc. | 5.23M | 5.4% | SCHEDULE 13D/A ↗ |
| Jun 4, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Milton C. Ault III | 1.45M | 41.6% | SCHEDULE 13D/A ↗ |
| Jun 4, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Capital Group, Inc. | 1.82M | 41.6% | SCHEDULE 13D/A ↗ |
| Jun 4, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Lending, LLC | 1.64M | 37.5% | SCHEDULE 13D/A ↗ |
| Jun 4, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | ACG Alpha Management LLC | 180,000 | 4.1% | SCHEDULE 13D/A ↗ |
| Jun 4, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance GP LLC | 180,000 | 4.1% | SCHEDULE 13D/A ↗ |
| Jun 4, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance LP | 180,000 | 4.1% | SCHEDULE 13D/A ↗ |
| Jun 4, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Hyperscale Data, Inc. | 1.82M | 41.6% | SCHEDULE 13D/A ↗ |
| May 29, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Milton C. Ault III | 1.45M | 35.7% | SCHEDULE 13D/A ↗ |
| May 29, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Capital Group, Inc. | 1.56M | 35.7% | SCHEDULE 13D/A ↗ |
| May 29, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Ault Lending, LLC | 1.43M | 32.7% | SCHEDULE 13D/A ↗ |
| May 29, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | ACG Alpha Management LLC | 130,000 | 3.0% | SCHEDULE 13D/A ↗ |
| May 29, 2026 | SCHEDULE 13D/A (amended) | YFOR YYForce Inc. | Alpha Structured Finance GP LLC | 130,000 | 3.0% | SCHEDULE 13D/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:31 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances